feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / New Blood Test Unlocks Brain Cancer Secrets

New Blood Test Unlocks Brain Cancer Secrets

31 Jan

•

Summary

  • A new device analyzes blood to understand brain messages.
  • It monitors glioblastoma's response to treatment in real-time.
  • The technology aims to improve survival rates for brain cancer.
New Blood Test Unlocks Brain Cancer Secrets

A groundbreaking diagnostic device developed by University of Queensland doctors promises to transform the treatment of glioblastoma, a highly aggressive brain cancer. Dubbed the Phenotype Analyzer Chip, this innovative technology offers a new way to understand messages within the brain through a simple blood test.

Led by Dr. Richard Lobb and Dr. Zhen Zhang, the device acts as a 'window to the brain,' providing fast and accurate information about the cancer's biological activity. It specifically analyzes how glioblastoma responds to ongoing treatment, potentially negating the need for more invasive procedures and thereby enhancing patient survival rates.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
trending

Tanker stalls Mumbai-Pune expressway

trending

ChatGPT outage reported today

trending

IT index plummets

trending

Anthropic AI triggers 'SaaSpocalypse'

trending

HAL out of stealth jet

trending

India U19 World Cup Semi

trending

India vs South Africa warm-up

trending

Lakers beat Nets, 112-100

trending

HDFC Bank share price target

The Phenotype Analyzer Chip is a new diagnostic device that uses a blood test to understand messages in the brain and monitor glioblastoma's response to treatment.
It provides real-time information on how glioblastoma responds to treatment, potentially removing the need for invasive procedures and improving survival rates.
Doctors from the University of Queensland's Australian Institute for Bioengineering and Nanotechnology developed this innovative technology.

Read more news on

Healthside-arrow

You may also like

Woman Runs 12 Half Marathons for Brain Tumor Charity

27 Jan • 38 reads

article image

New Blood Test Predicts Breast Cancer Treatment Success

19 Jan • 95 reads

article image

Young Chloe Honored for Courageous Cancer Battle

16 Jan • 80 reads

article image

New Hope for Glioblastoma: £2.6m Research Centre Opens

13 Dec, 2025 • 260 reads

article image

King Charles' Cancer Fight: Precautionary Treatment Ahead

13 Dec, 2025 • 288 reads

article image